www.fdanews.com/articles/102501-athersys-angiotech-announce-authorization-of-stem-cell-clinical-trial
Athersys, Angiotech Announce Authorization of Stem Cell Clinical Trial
December 20, 2007
Co-developers Athersys Inc. and Angiotech Pharmaceuticals Inc. say they have received authorization from the U.S. Food and Drug Administration to begin clinical trials of a stem cell-based treatment for heart attacks.
The Canadian Press
The Canadian Press